ACUTROL C 800MG TAB

Description

ACUTROL C 800MG TABLET is manufactured by Intas Pharmaceuticals Ltd and is indicated for the treatment of hyperphosphatemia in patients with end-stage renal disease (ESRD) or chronic kidney disease (CKD) on dialysis. Elevated phosphate levels can lead to complications such as itchy skin, bone pain, and an increased risk of fractures. This medication works by binding to phosphate from food in the digestive tract, preventing its absorption into the bloodstream.​

Key Features:

• Active Ingredient: Sevelamer Carbonate 800mg

• Formulation: Film-coated tablets

• Manufacturer: Intas Pharmaceuticals Ltd

• Indication: Hyperphosphatemia in CKD patients on dialysis

• Mechanism of Action: Phosphate binder​

Mechanism of Action: Sevelamer Carbonate, the active ingredient in ACUTROL C 800MG TABLET, binds to dietary phosphate in the gastrointestinal tract. This binding prevents phosphate from being absorbed into the bloodstream, thereby lowering serum phosphate levels. By controlling phosphate levels, it helps prevent complications associated with hyperphosphatemia in CKD patients.​

Indications:

• Primary Use: Treatment of hyperphosphatemia in CKD patients on dialysis

• Other Uses: May be used off-label for other conditions as determined by a healthcare provider​

Dosage and Administration:

• Typical Dosage: 1–2 tablets (800mg each) taken with meals, as directed by a healthcare provider.

• Administration: Swallow tablets whole; do not chew, crush, or break.

• Monitoring: Regular monitoring of serum phosphate levels is recommended during treatment.​